 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H17N3O2 |
| Molar mass | 307.353 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Anitrazifen is a drug displaying COX-2 inhibitor activity.[1]
|
| |
|---|---|
| pyrazolones / pyrazolidines |
|
| salicylates |
|
| acetic acid derivatives and related substances |
|
| oxicams |
|
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) |
|
| COX-2 inhibitors (coxibs) |
|
| other |
|
| NSAID combinations |
|
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
| |
|
| |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receptor (ligands) |
| ||||||||||||||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
 | This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
